abstract |
Disclosed are a CD47 antibody, an antigen-binding fragment and the medical use thereof. Further, disclosed are a chimeric antibody and humanized antibody comprising the CDR region of the CD47 antibody, a pharmaceutical composition comprising the CD47 antibody and an antigen-binding fragment thereof, and the use thereof as an anticancer drug. |